| All figures in €'000 | Notes | 2017 | 2016 |
| Revenue | (8) | 608,743 | 590,559 |
| Other revenue | (9) | 19,424 | 19,810 |
| Total revenue | 628,167 | 610,369 | |
| Commission expenses | (10) | -309,344 | -298,505 |
| Interest expenses | (11) | -1,055 | -1,711 |
| Loan loss provisions | -511 | -1,619 | |
| Personnel expenses | (12) | -123,245 | -121,847 |
| Depreciation and impairment | (13) | -15,293 | -23,962 |
| Other operating expenses | (14) | -143,607 | -145,137 |
| Earnings from investments accounted for using the equity method | (15) | 2,487 | 2,106 |
| Earnings before interest and tax (EBIT) | 37,600 | 19,694 | |
| Other interest and similar income | 209 | 906 | |
| Other interest and similar expenses | -1,433 | -1,851 | |
| Finance cost | (16) | -1,223 | -946 |
| Earnings before tax (EBT) | 36,377 | 18,748 | |
| Income taxes | (17) | -8,582 | -4,052 |
| Net profit | 27,796 | 14,696 | |
| Of which attributable to | |||
| owners of the parent company | 27,796 | 14,696 | |
| Earnings per share in € | (18) | ||
| basic/diluted | 0.25 | 0.13 | |
| All figures in €'000 | Notes | 2017 | 2016 |
| Net profit | 27,796 | 14,696 | |
| Gains/losses due to the revaluation of defined benefit obligations | (27) | 821 | -5,387 |
| Deferred taxes on non-reclassifiable gains/losses | (17) | -253 | 1,602 |
| Non-reclassifiable gains/losses | 568 | -3,784 | |
| Gains/losses from changes in the fair value of available-for-sale securities | (23) | -595 | 140 |
| Deferred taxes on reclassifiable gains/losses | (17) | 301 | -100 |
| Reclassifiable gains/losses | -293 | 40 | |
| Other comprehensive income | 274 | -3,744 | |
| Total comprehensive income | 28,070 | 10,952 | |
| Of which attributable to | |||
| owners of the parent company | 28,070 | 10,952 | |
